HyperventilationRecorder for CAE/ADHD Differential Diagnosis
Screening for Childhood Absence Epilepsy (CAE)
Key Facts
About Eysz
Eysz addresses a critical diagnostic challenge in pediatric primary care: distinguishing between Childhood Absence Epilepsy (CAE) and Attention-Deficit/Hyperactivity Disorder (ADHD), which present with similar symptoms like staring and inattention. The company's core product is the Eysz HyperventilationRecorder, an FDA-registered Class II medical device that uses a gamified mobile application to guide a hyperventilation procedure—a known trigger for absence seizures—and records objective video data for clinical review. Validated in an NIH-funded study, the device offers a scalable, in-office tool to improve diagnostic accuracy, reduce unnecessary neurology referrals, and optimize treatment pathways for common pediatric neurobehavioral conditions.
View full company profile